MedTrace Logo

Epidemiological Analysis for Hereditary Angioedema Disease

NCT03558009 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2318

Last updated 2022-04-25

No results posted yet for this study

Summary

An international, multicenter, epidemiological, observational study investigating the prevalence of Hereditary Angioedema (HAE) disease among participants with recurrent episodes of abdominal pain of no obvious etiology.

Conditions

Sponsors & Collaborators

  • CENTOGENE GmbH Rostock

    lead INDUSTRY

Principal Investigators

  • Peter Bauer, MD · CENTOGENE GmbH

Eligibility

Min Age
2 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2022-04-11
Completion
2022-04-11

Countries

  • Germany
  • Italy
  • Japan
  • Poland
  • Turkey (Türkiye)
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03558009 on ClinicalTrials.gov